These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23114136)

  • 1. [Methylation of FHIT gene promoter region in DNA from plasma of patients with myelodysplastic syndromes and demethylating effect of decitabine].
    Deng YF; Zhang L; Zhang XQ; Hu MQ; Dai D; Zhang XZ; Xu YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1144-8. PubMed ID: 23114136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
    Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome.
    Lin J; Yao DM; Qian J; Wang YL; Han LX; Jiang YW; Fei X; Cen JN; Chen ZX
    Leuk Res; 2008 Oct; 32(10):1541-5. PubMed ID: 18367246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of the 5' CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia.
    Zheng S; Ma X; Zhang L; Gunn L; Smith MT; Wiemels JL; Leung K; Buffler PA; Wiencke JK
    Cancer Res; 2004 Mar; 64(6):2000-6. PubMed ID: 15026336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome.
    Iwai M; Kiyoi H; Ozeki K; Kinoshita T; Emi N; Ohno R; Naoe T
    Leukemia; 2005 Aug; 19(8):1367-75. PubMed ID: 15902282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant promoter methylation of Dab2 gene in myelodysplastic syndrome.
    Yang Y; Zhang Q; Xu F; Chang C; Li X
    Eur J Haematol; 2012 Dec; 89(6):469-77. PubMed ID: 23005040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methylation of P15INK4B gene in patients with myelodysplastic syndromes and demethylating effects of drugs].
    Ye XS; Liu T; Cui X; Meng WT; Xi YM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):57-9. PubMed ID: 17294728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of hypermethylation of DLC-1 gene in myelodysplastic syndrome patients and effects of decitabine on DLC-1 gene expression].
    Fu HY; Zhou HR; Yan JG; Chen CJ; Shen JZ
    Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(6):412-417. PubMed ID: 28219126
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS.
    Leone G; Voso MT; Teofili L; Lübbert M
    Clin Immunol; 2003 Oct; 109(1):89-102. PubMed ID: 14585280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment.
    Daskalakis M; Nguyen TT; Nguyen C; Guldberg P; Köhler G; Wijermans P; Jones PA; Lübbert M
    Blood; 2002 Oct; 100(8):2957-64. PubMed ID: 12351408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [p15(INK4B) methylation on prognosis and response to decitabine in patients with MDS].
    Zhang Y; Song LX; Wu LY; Chang CK; Li X
    Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):237-41. PubMed ID: 23683424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decitabine treatment could ameliorate primary iron-overload in myelodysplastic syndrome patients.
    Shucheng G; Chunkang C; Youshan Z; Juan G; Chengming F; Xi Z; Chao X; Xiao L
    Cancer Invest; 2015 Apr; 33(4):98-106. PubMed ID: 25699651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical observation of decitabine-treating patients with myelodysplastic syndrome and acute myeloid leukemia].
    Yang H; Zhu HY; Jiang MM; Wang QS; Han XP; Huang WR; Jing Y; Wang SH; Zhang SS; Mei JH; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):121-5. PubMed ID: 23484704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical Value of p15, DAPK, SOCS1 and FHIT Genes Combined Detection in the Early Diagnosis and Prognosis Evaluation of Myelodysplastic Syndrome].
    Deng CY; Chen S; Jiang M; Chen R; Nilupar T; Wang H; Hao JP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1751-1755. PubMed ID: 29262910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of 5-Aza-dC on FHIT gene expression in hepatocellular carcinoma cell line HepG2].
    Li HL; Zhang WD; Li WT; Yin CG
    Ai Zheng; 2009 Sep; 28(9):967-71. PubMed ID: 19728916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demethylating agents in myeloid malignancies.
    Garcia-Manero G
    Curr Opin Oncol; 2008 Nov; 20(6):705-10. PubMed ID: 18841054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical Significance of ID4 Gene Mehtylation in Demethylation-Treated MDS Cell Line and 2 MDS Patients].
    Kang HY; Wang XR; Gao L; Wang W; Li MY; Wang LL; Wang CB; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):455-9. PubMed ID: 25948204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor gene BLU is frequently downregulated by promoter hypermethylation in myelodysplastic syndrome.
    Yang Y; Zhang Q; Xu F; Wu L; He Q; Li X
    J Cancer Res Clin Oncol; 2012 May; 138(5):729-37. PubMed ID: 22246278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies.
    Hackanson B; Robbel C; Wijermans P; Lübbert M
    Ann Hematol; 2005 Dec; 84 Suppl 1():32-8. PubMed ID: 16292549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FHIT promoter methylation status, low protein and high mRNA levels in patients with non-small cell lung cancer.
    Czarnecka KH; Migdalska-Sęk M; Domańska D; Pastuszak-Lewandoska D; Dutkowska A; Kordiak J; Nawrot E; Kiszałkiewicz J; Antczak A; Brzeziańska-Lasota E
    Int J Oncol; 2016 Sep; 49(3):1175-84. PubMed ID: 27572663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.